2月5日，市委书记张恩惠就贯彻省两会和市委全会、市委经济工作会议精神到他所包保的企 业、重点项目调研，强调要坚定不移抓经济促发展，稳企业、稳运行，只争朝夕、紧抓快 干，全力推动一季度"开门红"，为全年高质量发展、实现"十五五"良好开局打下坚实基础。 2月5日，市委书记张恩惠在吉林省科英激光有限公司调研检测中心和精密加工中心运行情况，以及医药 装备研发生产情况。 吉林省科英激光有限公司研发的激光医疗设备产品远销多个国家和地区。张恩惠走进生产车间、研发部 门，了解产品系列、功能和订单情况，听取企业下一步发展思路。希望持续加大研发投入，生产更多高 附加值产品，培养引入更多激光技术、智能制造等领域专业人才，不断提升企业核心竞争力。 2月5日，市委书记张恩惠在力旺地产宜居路项目地调研项目建设进展情况。 力旺地产宜居路项目是我市"好房子"试点项目之一，采用基坑气膜方式进行冬季施工，预计缩短工期3 个月。张恩惠详细了解新工艺的效果、成本、环保及安全情况，强调要在保证质量和安全前提下，加快 施工进度，大力推进好房子、好小区、好社区、好城区建设。要积极探索北方冬季施工的新路径，加强 现场消防安全、施工安全、用电安全、防风防雪等 ...

Core Viewpoint - The development trajectory of Qizhi Laser reflects the growing pains of the domestic laser medical equipment industry, facing multiple operational risks despite backing from Xinyang Holdings and previously holding a leading market position in the aesthetic medical sector [1] Financial Performance - In 2024, Qizhi Laser reported total revenue of 270 million yuan, a year-on-year increase of 0.30%, while net profit fell to 33.19 million yuan, a decline of 38.81% compared to the previous year [1] Strategic Transformation Challenges - The company's strategic transformation has been inconsistent, attempting to shift away from the aesthetic medical label towards serious medical fields like dermatology and urology, but this move has not gained market recognition [1][2] - The withdrawal of the IPO plan highlights deeper contradictions in the business logic, as the company still heavily relies on aesthetic medical institutions and core products [1] Governance and Management Issues - The reliance on a single major shareholder, Xinyang Holdings, which holds nearly 88% of shares, has weakened decision-making independence, leading to instability in management following the termination of the IPO plan [2] - The departure of the founding team and professional managers reflects strategic disagreements between capital-focused short-term returns and the technical team's preference for long-term R&D investment [2] Market Pressures - Qizhi Laser faces dual pressures from international giants entering the Chinese market and domestic low-cost competitors engaging in price wars, leading to a cycle of technological homogenization and profit erosion [3] - The price of photon skin rejuvenation equipment has dropped to the hundred-yuan level, intensifying competition [3] Operational Imbalances - Despite holding multiple medical device registrations, the company has lagged in product iteration compared to market demand, particularly in emerging health trends [3] - The growing accounts receivable and shrinking cash flow from operating activities indicate deteriorating capital turnover efficiency, revealing a disconnect between reported profits and actual cash flow [3] Summary of Challenges - The challenges faced by Qizhi Laser represent a disconnect between traditional paths and emerging demands during the industry's transformation period, with weakened technological advantages, increased governance risks, and fragile operational models [4]

Core Viewpoint - The laser medical equipment industry in China is experiencing rapid growth driven by national policy support, increasing market demand, and technological breakthroughs, with a projected market size of approximately 5.8 billion yuan in 2024 and expected to exceed 6 billion yuan in 2025 [1][5][9]. Industry Definition and Classification - Laser medical equipment refers to devices that utilize laser technology for disease diagnosis, treatment, or rehabilitation, characterized by precision, minimally invasive procedures, and high efficiency [1][3]. - The industry can be categorized into laser medical equipment manufacturing and laser medical services, with applications across various clinical departments [1][3]. Current Development Status - The application of laser technology in medicine has made significant progress, with a wide range of laser medical devices available for treating hundreds of diseases in various clinical settings [5][9]. - The domestic market for laser medical devices has entered a phase of "mid-end dominance and high-end breakthroughs," with the low-end market largely self-sufficient, while high-precision and ultra-fast laser fields require long-term technological accumulation [9][23]. Market Size and Growth - The market size for laser medical equipment in China is projected to be around 5.8 billion yuan in 2024, with expectations to surpass 6 billion yuan in 2025, indicating a positive long-term trend for the industry [1][9]. Domestic Production and Market Dynamics - The domestic production rate of laser medical equipment is expected to reach approximately 67.01% in 2024 and is projected to reach 70% in 2025, reflecting a rapid increase in domestic substitution [9][23]. - The industry is characterized by a competitive landscape where local companies are gradually gaining market share, particularly in the mid and low-end segments, while high-end markets remain dominated by international giants [13][15]. Key Companies - Major companies in the laser medical equipment sector include Qizhi Laser, Ruike Laser, United Imaging Healthcare, Pudong Medical, and others, with a focus on innovation and technology development [13][15]. - Qizhi Laser has achieved significant milestones with 22 medical device product registrations and 112 patents, focusing on various medical fields [15]. - Ruike Laser has expanded into the medical sector, developing solutions for aesthetic and dental applications, with reported revenues of 3.68 billion yuan in 2023 [19][21]. Industry Trends - The laser medical equipment industry is undergoing a transformation towards smart, high-end, compact, specialized, and environmentally friendly technologies, with advancements in various scientific fields enhancing the capabilities of laser medical technology [23]. - The future of laser medical technology is expected to benefit a broader audience, including public and private hospitals, beauty markets, and home-use devices, indicating a wide application and strong demand [23].